Papers by Daisuke Yabe
5 results
- The Lancet Diabetes & Endocrinology
Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3 trial
Randomised trial in 401 peopleOrforglipron - ADA Scientific Sessions 2026 Abstract
Efficacy and Hypoglycemia Outcomes with Once-Weekly IcoSema vs. Comparators in T2D by Baseline BMI: COMBINE 1–3
Trial in peopleInterventions
- ADA Scientific Sessions 2026 Abstract
Efficacy and Hypoglycemia Outcomes with Once-Weekly IcoSema vs. Comparators in T2D by Baseline A1C: COMBINE 1–3
Trial in peopleInterventions